Fresenius-kabi Innovation in Aseptic Compounding Award 2024

Supported by:

This award category is open to qualified, trained pharmacists and technicians engaged in the preparation of injectable and other sterile products for individual patient use.

The judges will be looking for an individual within a pharmacy department or a pharmacy team that can best demonstrate innovation in safety and quality within their department while incorporating innovative initiatives. This could be through SOPs, cost saving projects, submitted posters, clinical trials medication, interaction with other departments, identification and fulfilment of training needs and other.
The project/process should show measurable results of having improved the service that they provide to the pharmacy department or their patients. This award does not differentiate between large and small hospitals. It also does not differentiate between a public and private hospital. The entry needs to demonstrate measurable results attributable to the innovations.

Each submission will be judged by an independent judging panel.

All entries will be handled in the strictest confidence and will not be made available to any party not involved with judging the awards. If your entry is shortlisted, the awards organisers may wish to reproduce a summary of your entry, photographs and any other supporting materials in the finalists’ booklet or within other materials they produce to promote the awards, including all press releases.